Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2015

01.02.2015 | Research Article

Survey of patients’ experiences and their certainty of suspected adverse drug reactions

verfasst von: Jarernsiripornkul Narumol, Patsuree Arunrot, Janet Krska

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Background Patients are best placed to recognize and monitor their own experiences of adverse drug reactions (ADRs), however they may need medicines information to help them do so. In Thailand patients rarely receive information leaflets, but are permitted to report ADRs directly to the regulator. Objectives To determine frequency of ADRs reported by hospital out-patients, the information sources used to evaluate suspected ADRs and patients’ confidence in ADR identification. Setting Srinagarind hospital in Khon Kaen, the second-largest province of North-eastern Thailand. Methods A questionnaire designed for self-completion and distributed to out-patients at this tertiary hospital using systematic random sampling over a 2-month period. Main outcome measures Frequency of reported ADRs, information sources confirming ADRs and degree of confidence in ADR identification. Results Of 1,195 questionnaires distributed, 1,044 usable responses were obtained (87.4 %). The majority of respondents were female (57.1 %) with average age 39.6 ± 13.6 years. Of 1,044 valid questionnaires, 257 (24.7 %) patients indicated they had experienced an ADR with high (56.0 %) and moderate (31.9 %) degree of confidence in ADR identification. The most frequent causative agent was an anti-infective (19.1 % of the patients). Major sources of information used for ADR assessment were healthcare professionals (35.5 %) and past ADR experience (25.5 %), with information leaflets being used infrequently (14.6 %). Conclusions This study showed high frequency of ADRs among Thai patients who were mostly confident about casual relationships with medicines. Patients mostly used healthcare professionals as confirmation source to evaluate suspected ADRs. Reliable medicines information sources such as information leaflets should be made more widely available.
Literatur
1.
Zurück zum Zitat Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.PubMedCrossRef Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.PubMedCrossRef
2.
Zurück zum Zitat US General Accounting Office. FDA Drug Review: Postapproval Risks, 1976-85. Washington: US General Accounting Office; 1990. US General Accounting Office. FDA Drug Review: Postapproval Risks, 1976-85. Washington: US General Accounting Office; 1990.
3.
Zurück zum Zitat Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.PubMedCrossRef
4.
Zurück zum Zitat Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4:e4439.PubMedCentralPubMedCrossRef Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4:e4439.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.PubMedCentralPubMedCrossRef Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf. 2012;35:769–81.PubMedCentralPubMedCrossRef Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf. 2012;35:769–81.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53:318–25.PubMedCentralPubMedCrossRef Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53:318–25.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 2006;29:385–96.PubMedCrossRef Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 2006;29:385–96.PubMedCrossRef
9.
Zurück zum Zitat de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008;31:515–24.PubMedCrossRef de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008;31:515–24.PubMedCrossRef
10.
Zurück zum Zitat van Hunsel F, Harmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35:45–60.PubMedCrossRef van Hunsel F, Harmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35:45–60.PubMedCrossRef
11.
Zurück zum Zitat Krueger JL, Hermansen-Kobulnicky CJ. Patient perspective of medication information desired and barriers to asking pharmacists questions. J Am Pharm Assoc. 2011;51:510–9.CrossRef Krueger JL, Hermansen-Kobulnicky CJ. Patient perspective of medication information desired and barriers to asking pharmacists questions. J Am Pharm Assoc. 2011;51:510–9.CrossRef
12.
Zurück zum Zitat Elkalmi R, Hassali MA, Al-Lela OQ, Jawad Awadh AI, Al-Shami AK, Jamshed SQ. Adverse drug reactions reporting : knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci. 2013;5:224–8.PubMedCentralPubMedCrossRef Elkalmi R, Hassali MA, Al-Lela OQ, Jawad Awadh AI, Al-Shami AK, Jamshed SQ. Adverse drug reactions reporting : knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci. 2013;5:224–8.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63:148–56.PubMedCentralPubMedCrossRef Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63:148–56.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15:1–234.PubMedCrossRef Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15:1–234.PubMedCrossRef
15.
Zurück zum Zitat Rolfes L, van Hunsel F, Wilkes S, Grootheest KV, Puijenbroek EV. Adverse drug reaction reports of patients and healthcare professionals-differences in reported information. Pharmacoepidemiol Drug Saf. 2014. [Epub ahead of print]. Rolfes L, van Hunsel F, Wilkes S, Grootheest KV, Puijenbroek EV. Adverse drug reaction reports of patients and healthcare professionals-differences in reported information. Pharmacoepidemiol Drug Saf. 2014. [Epub ahead of print].
16.
Zurück zum Zitat Jarernsiripornkul N, Senacom P, Uchaipicha V, Chaipichit N, Krska J. Patient reporting of suspected ADRs to anti-epileptic drugs in Thailand: factors affecting attribution accuracy. Epilepsy Behav. 2012;24:102–6.PubMedCrossRef Jarernsiripornkul N, Senacom P, Uchaipicha V, Chaipichit N, Krska J. Patient reporting of suspected ADRs to anti-epileptic drugs in Thailand: factors affecting attribution accuracy. Epilepsy Behav. 2012;24:102–6.PubMedCrossRef
18.
Zurück zum Zitat Inch J, Watson MC, Anakwe-Umeh S. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Drug Saf. 2012;35:807–18.PubMedCrossRef Inch J, Watson MC, Anakwe-Umeh S. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Drug Saf. 2012;35:807–18.PubMedCrossRef
19.
Zurück zum Zitat Jarernsiripornkul N, Chaisrisawadsuk S, Chaiyakum A, Krska J. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. Pharm World Sci. 2009;31:559–64.PubMedCrossRef Jarernsiripornkul N, Chaisrisawadsuk S, Chaiyakum A, Krska J. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. Pharm World Sci. 2009;31:559–64.PubMedCrossRef
20.
Zurück zum Zitat Anderson C, Krska J, Murphy E, Avery A. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol. 2011;72:806–22.PubMedCentralPubMedCrossRef Anderson C, Krska J, Murphy E, Avery A. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol. 2011;72:806–22.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat van Hunsel F, van der Welle C, Passier A, van Puijenbroek E, van Grootheest K. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol. 2010;66:1143–50.PubMedCentralPubMedCrossRef van Hunsel F, van der Welle C, Passier A, van Puijenbroek E, van Grootheest K. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol. 2010;66:1143–50.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Valente S, Murray LP. Creative strategies to improve patient safety: allergies and adverse drug reactions. J Nurses Staff Dev. 2011;27:E1–5.PubMedCrossRef Valente S, Murray LP. Creative strategies to improve patient safety: allergies and adverse drug reactions. J Nurses Staff Dev. 2011;27:E1–5.PubMedCrossRef
23.
Zurück zum Zitat Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–80.PubMedCrossRef Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–80.PubMedCrossRef
24.
Zurück zum Zitat Krska J, Jones L, McKinney J, Wilson C. Medicines safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098–103.PubMedCrossRef Krska J, Jones L, McKinney J, Wilson C. Medicines safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098–103.PubMedCrossRef
25.
Zurück zum Zitat Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust. 2006;184:321–4.PubMed Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust. 2006;184:321–4.PubMed
26.
Zurück zum Zitat McLernon DJ, Bond CM, Lee AJ, Watson MC, Hannaford PC, Fortnum H, et al. Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf. 2011;20:523–31.PubMedCrossRef McLernon DJ, Bond CM, Lee AJ, Watson MC, Hannaford PC, Fortnum H, et al. Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf. 2011;20:523–31.PubMedCrossRef
27.
Zurück zum Zitat Center Health Product Vigilance. ADR reporting 2012. Bangkok: Thai Food and Drug Administration, Ministry of Public Health; 2012. Center Health Product Vigilance. ADR reporting 2012. Bangkok: Thai Food and Drug Administration, Ministry of Public Health; 2012.
28.
Zurück zum Zitat Krska J, Anderson C, Murphy E, Avery AJ. How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme. Drug Saf. 2011;34:429–36.PubMedCrossRef Krska J, Anderson C, Murphy E, Avery AJ. How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme. Drug Saf. 2011;34:429–36.PubMedCrossRef
29.
Zurück zum Zitat Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27:243–8.PubMedCrossRef Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27:243–8.PubMedCrossRef
30.
Zurück zum Zitat Phueanpinit P, Jarernsiripornkul N, Pongwecharak J, Krska J. Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2014;36:1205–12. Phueanpinit P, Jarernsiripornkul N, Pongwecharak J, Krska J. Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2014;36:1205–12.
Metadaten
Titel
Survey of patients’ experiences and their certainty of suspected adverse drug reactions
verfasst von
Jarernsiripornkul Narumol
Patsuree Arunrot
Janet Krska
Publikationsdatum
01.02.2015
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2015
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-0060-5

Weitere Artikel der Ausgabe 1/2015

International Journal of Clinical Pharmacy 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.